1
Clinical Trials associated with Allogeneic T cell therapy(Smart Immune SAS)A Phase I/II Study Evaluating the Safety and the Efficacy of SMART101 Injection to Accelerate Immune Reconstitution After T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric and Adult Patients With Hematological Malignancies
The purpose of this study is to evaluate the safety and the efficacy of SMART101 (Human T Lymphoid Progenitor (HTLP)) injection to accelerate immune reconstitution after T cell depleted allogeneic hematopoietic stem cell transplantation (HSCT) in adult and pediatric patients with hematological malignancies.
100 Clinical Results associated with Allogeneic T cell therapy(Smart Immune SAS)
100 Translational Medicine associated with Allogeneic T cell therapy(Smart Immune SAS)
100 Patents (Medical) associated with Allogeneic T cell therapy(Smart Immune SAS)
100 Deals associated with Allogeneic T cell therapy(Smart Immune SAS)